These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 29307324)

  • 1. Evaluation of Cognition and Cortical Excitability in Huntington's Disease.
    Kamble N; Netravathi M; Nagaraju BC; Lenka A; Kumar K; Sowmya V; Jain S; Pal PK
    Can J Neurol Sci; 2018 Mar; 45(2):176-181. PubMed ID: 29307324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cortical inhibitory deficits in premanifest and early Huntington's disease.
    Philpott AL; Cummins TDR; Bailey NW; Churchyard A; Fitzgerald PB; Georgiou-Karistianis N
    Behav Brain Res; 2016 Jan; 296():311-317. PubMed ID: 26416671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cortical excitability changes in patients of vascular parkinsonism with cognitive impairment.
    Agrawal A; Bhattacharya A; Kamble N; Mailankody P; Yadav R; Pal PK
    Parkinsonism Relat Disord; 2023 Nov; 116():105869. PubMed ID: 37783026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal intracortical facilitation in early-stage Huntington's disease.
    Nardone R; Lochner P; Marth R; Ausserer H; Bratti A; Tezzon F
    Clin Neurophysiol; 2007 May; 118(5):1149-54. PubMed ID: 17336146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of cortical GABAergic inhibition correlates with working memory impairment in recent onset schizophrenia.
    Takahashi S; Ukai S; Kose A; Hashimoto T; Iwatani J; Okumura M; Tsuji T; Shinosaki K
    Schizophr Res; 2013 May; 146(1-3):238-43. PubMed ID: 23523695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal motor cortex excitability in preclinical and very early Huntington's disease.
    Schippling S; Schneider SA; Bhatia KP; Münchau A; Rothwell JC; Tabrizi SJ; Orth M
    Biol Psychiatry; 2009 Jun; 65(11):959-65. PubMed ID: 19200948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in thresholds for intracortical excitability in chronic stroke: more than just altered intracortical inhibition.
    Edwards JD; Meehan SK; Linsdell MA; Borich MR; Anbarani K; Jones PW; Ferris J; Boyd LA
    Restor Neurol Neurosci; 2013; 31(6):693-705. PubMed ID: 23963339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Lumbar Drainage on Cortical Excitability in Normal Pressure Hydrocephalus.
    Agrawal A; Bhattacharya A; Kamble N; Yadav R; Pal PK
    Can J Neurol Sci; 2021 Mar; 48(2):253-258. PubMed ID: 32741415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Motor cortical excitability studied with repetitive transcranial magnetic stimulation in patients with Huntington's disease.
    Lorenzano C; Dinapoli L; Gilio F; Suppa A; Bagnato S; Currà A; Inghilleri M; Berardelli A
    Clin Neurophysiol; 2006 Aug; 117(8):1677-81. PubMed ID: 16793338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noninvasive brain stimulation in Huntington's disease.
    Berardelli A; Suppa A
    Handb Clin Neurol; 2013; 116():555-60. PubMed ID: 24112923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impairments in motor-cortical inhibitory networks across recent-onset and chronic schizophrenia: a cross-sectional TMS Study.
    Strube W; Wobrock T; Bunse T; Palm U; Padberg F; Malchow B; Falkai P; Hasan A
    Behav Brain Res; 2014 May; 264():17-25. PubMed ID: 24509248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cortical excitability in drug naive juvenile myoclonic epilepsy.
    Puri V; Sajan PM; Chowdhury V; Chaudhry N
    Seizure; 2013 Oct; 22(8):662-9. PubMed ID: 23746624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of test TMS intensity on short-interval intracortical inhibition in different excitability states.
    Garry MI; Thomson RH
    Exp Brain Res; 2009 Feb; 193(2):267-74. PubMed ID: 18974984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysfunctions of cortical excitability in drug-naïve posttraumatic stress disorder patients.
    Rossi S; De Capua A; Tavanti M; Calossi S; Polizzotto NR; Mantovani A; Falzarano V; Bossini L; Passero S; Bartalini S; Ulivelli M
    Biol Psychiatry; 2009 Jul; 66(1):54-61. PubMed ID: 19368897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normal cortical excitability in Myoclonus-Dystonia--a TMS study.
    van der Salm SM; van Rootselaar AF; Foncke EM; Koelman JH; Bour LJ; Bhatia KP; Rothwell JC; Tijssen MA
    Exp Neurol; 2009 Apr; 216(2):300-5. PubMed ID: 19118553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced motor cortical inhibition in migraine: A blinded transcranial magnetic stimulation study.
    Neverdahl JP; Omland PM; Uglem M; Engstrøm M; Sand T
    Clin Neurophysiol; 2017 Dec; 128(12):2411-2418. PubMed ID: 29096214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex differences in mild vascular cognitive impairment: A multimodal transcranial magnetic stimulation study.
    Cantone M; Fisicaro F; Ferri R; Bella R; Pennisi G; Lanza G; Pennisi M
    PLoS One; 2023; 18(3):e0282751. PubMed ID: 36867595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced cortical inhibition in first-episode schizophrenia.
    Wobrock T; Schneider M; Kadovic D; Schneider-Axmann T; Ecker UK; Retz W; Rösler M; Falkai P
    Schizophr Res; 2008 Oct; 105(1-3):252-61. PubMed ID: 18625547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A GABBR2 gene variant modifies pathophysiology in Huntington's disease.
    Philpott AL; Fitzgerald PB; Bailey NW; Churchyard A; Georgiou-Karistianis N; Cummins TD
    Neurosci Lett; 2016 May; 620():8-13. PubMed ID: 27033668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inter-session reliability of short-interval intracortical inhibition measured by threshold tracking TMS.
    Matamala JM; Howells J; Dharmadasa T; Trinh T; Ma Y; Lera L; Vucic S; Burke D; Kiernan MC
    Neurosci Lett; 2018 May; 674():18-23. PubMed ID: 29501687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.